Multinational companies in China’s vaccine market face headwinds amid an anti-co...
Valneva will work with local health authorities and wholesalers on the French is...
The government of Alberta has announced a collaboration with Siemens Healthineer...
Today marks World TB Day 2025 with the WHO calling for more investment into TB t...
Augustine Therapeutics has raised €78m ($85m) in funding to support the developm...
The FDA has granted approval for the IND application of Everest Medicines’ tumou...
AstraZeneca has announced a $2.5bn investment to establish the company’s sixth w...
J&J is the latest pharma company to announce a major US investment, committing t...
Amvuttra is now approved in the US to treat both cardiomyopathy and polyneuropat...
Sermonix Pharmaceuticals and Regor have announced a strategic partnership aimed ...
TMP-301 is being investigated in clinical trials for alcohol use disorder and co...
NMPA has granted conditional approval for Hutchmed’s Tazverik to treat adults wi...
Ahead of World Tuberculosis Day on 24 March, the WHO has said that global fundin...
Clinical trials must use effective electronic data capture platforms that priori...
Menarini Group has announced a partnership with VisualDx to enhance the diagnosi...